PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsDermatitis
MeSH D003872 - dermatitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012871:Skin diseases
$
Success rate
D003872: 
Dermatitis
D000169:Acrodermatitis
0 Companies
0 Drugs
Success rate
D003873:Exfoliative dermatitis
$
Success rate
D003874:Dermatitis herpetiformis
D003875:Drug eruptions
0 Companies
0 Drugs
Success rate
D003876:Atopic dermatitis
D003877:Contact dermatitis
D004485:Eczema
$
Success rate
D007402:Intertrigo
0 Companies
0 Drugs
Success rate
D009450:Neurodermatitis
0 Companies
0 Drugs
Success rate
D011855:Radiodermatitis
0 Companies
0 Drugs
Success rate
D012628:Seborrheic dermatitis
D019557:Perioral dermatitis
0 Companies
0 Drugs
Success rate
D063807:Dandruff
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaClobetasol Clobetasol  1994-02-16   
Vitamin a Vitamin A  1982-01-01   
PadagisClobetasol Clobetasol  1997-10-31   
Taro PharmaceuticalClobetasol Clobetasol  1996-07-12   
Clobetasol Clobetasol (emollient)  2000-05-17   
Glenmark PharmaceuticalsClobetasol Clobetasol  2017-03-20   
MylanClobetasol Impeklo  2020-05-19   
Clobetasol Olux  2000-05-26   
XiromedClobetasol Clobetasol  2018-04-17   
Lupin ResearchClobetasol Clobetasol  2018-03-26   
BayerNystatin, Clioquinol Nystaform  1982-01-01   
Vitamin a VI-dom-a  1982-01-01   
Cosette Pharmaceuticals Clobetasol Clobetasol  1994-02-16   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%
4/4
Phase 2
0%
0/11
Phase 3
48%
12/25
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Padagis
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use